Dong-E-E-Jiao Co.,Ltd. (SHE:000423)
62.50
-0.80 (-1.26%)
Apr 18, 2025, 3:04 PM CST
Dong-E-E-Jiao Revenue
In the year 2024, Dong-E-E-Jiao had annual revenue of 5.92B CNY with 25.57% growth. Dong-E-E-Jiao had revenue of 1.59B in the quarter ending December 31, 2024, with 23.67% growth.
Revenue
5.92B
Revenue Growth
+25.57%
P/S Ratio
6.78
Revenue / Employee
1.45M
Employees
4,095
Market Cap
40.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.92B | 1.21B | 25.57% |
Jan 1, 2024 | 4.72B | 673.45M | 16.66% |
Jan 1, 2023 | 4.04B | 192.83M | 5.01% |
Jan 1, 2022 | 3.85B | 439.55M | 12.89% |
Dec 31, 2020 | 3.41B | 439.36M | 14.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |